Cargando…

Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis

OBJECTIVE: Uridine has earlier been show to down modulate inflammation in models of lung inflammation. The aim of this study was to evaluate the anti-inflammatory effect of uridine in arthritis. METHODS: Arthritis was induced by intra-articular injection of mBSA in the knee of NMRI mice pre-immunize...

Descripción completa

Detalles Bibliográficos
Autores principales: Chenna Narendra, Sudeep, Chalise, Jaya Prakash, Magnusson, Mattias, Uppugunduri, Srinivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625961/
https://www.ncbi.nlm.nih.gov/pubmed/26512984
http://dx.doi.org/10.1371/journal.pone.0141863
_version_ 1782398054201032704
author Chenna Narendra, Sudeep
Chalise, Jaya Prakash
Magnusson, Mattias
Uppugunduri, Srinivas
author_facet Chenna Narendra, Sudeep
Chalise, Jaya Prakash
Magnusson, Mattias
Uppugunduri, Srinivas
author_sort Chenna Narendra, Sudeep
collection PubMed
description OBJECTIVE: Uridine has earlier been show to down modulate inflammation in models of lung inflammation. The aim of this study was to evaluate the anti-inflammatory effect of uridine in arthritis. METHODS: Arthritis was induced by intra-articular injection of mBSA in the knee of NMRI mice pre-immunized with mBSA. Uridine was either administered locally by direct injection into the knee joint or systemically. Systemic treatment included repeated injections or implantation of a pellet continuously releasing uridine during the entire experimental procedure. Anti-mBSA specific immune responses were determined by ELISA and cell proliferation and serum cytokine levels were determined by Luminex. Immunohistochemistry was used to identify cells, study expression of cytokines and adhesion molecules in the joint. RESULTS: Local administration of 25–100 mg/kg uridine at the time of arthritis onset clearly prevented development of joint inflammation. In contrast, systemic administration of uridine (max 1.5 mg uridine per day) did not prevent development of arthritis. Protection against arthritis by local administration of uridine did not affect the anti-mBSA specific immune response and did not prevent the rise in serum levels of pro-inflammatory cytokines associated with the triggering of arthritis. In contrast, local uridine treatment efficiently inhibited synovial expression of ICAM-1 and CD18, local cytokine production and recruitment of leukocytes to the synovium. CONCLUSION: Local, but not systemic administration of uridine efficiently prevented development of antigen-induced arthritis. The protective effect did not involve alteration of systemic immunity to mBSA but clearly involved inhibition of synovial expression of adhesion molecules, decreased TNF and IL-6 production and prevention of leukocyte extravasation. Further, uridine is a small, inexpensive molecule and may thus be a new therapeutic option to treat joint inflammation in RA.
format Online
Article
Text
id pubmed-4625961
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46259612015-11-06 Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis Chenna Narendra, Sudeep Chalise, Jaya Prakash Magnusson, Mattias Uppugunduri, Srinivas PLoS One Research Article OBJECTIVE: Uridine has earlier been show to down modulate inflammation in models of lung inflammation. The aim of this study was to evaluate the anti-inflammatory effect of uridine in arthritis. METHODS: Arthritis was induced by intra-articular injection of mBSA in the knee of NMRI mice pre-immunized with mBSA. Uridine was either administered locally by direct injection into the knee joint or systemically. Systemic treatment included repeated injections or implantation of a pellet continuously releasing uridine during the entire experimental procedure. Anti-mBSA specific immune responses were determined by ELISA and cell proliferation and serum cytokine levels were determined by Luminex. Immunohistochemistry was used to identify cells, study expression of cytokines and adhesion molecules in the joint. RESULTS: Local administration of 25–100 mg/kg uridine at the time of arthritis onset clearly prevented development of joint inflammation. In contrast, systemic administration of uridine (max 1.5 mg uridine per day) did not prevent development of arthritis. Protection against arthritis by local administration of uridine did not affect the anti-mBSA specific immune response and did not prevent the rise in serum levels of pro-inflammatory cytokines associated with the triggering of arthritis. In contrast, local uridine treatment efficiently inhibited synovial expression of ICAM-1 and CD18, local cytokine production and recruitment of leukocytes to the synovium. CONCLUSION: Local, but not systemic administration of uridine efficiently prevented development of antigen-induced arthritis. The protective effect did not involve alteration of systemic immunity to mBSA but clearly involved inhibition of synovial expression of adhesion molecules, decreased TNF and IL-6 production and prevention of leukocyte extravasation. Further, uridine is a small, inexpensive molecule and may thus be a new therapeutic option to treat joint inflammation in RA. Public Library of Science 2015-10-29 /pmc/articles/PMC4625961/ /pubmed/26512984 http://dx.doi.org/10.1371/journal.pone.0141863 Text en © 2015 Chenna Narendra et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chenna Narendra, Sudeep
Chalise, Jaya Prakash
Magnusson, Mattias
Uppugunduri, Srinivas
Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis
title Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis
title_full Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis
title_fullStr Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis
title_full_unstemmed Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis
title_short Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis
title_sort local but not systemic administration of uridine prevents development of antigen-induced arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625961/
https://www.ncbi.nlm.nih.gov/pubmed/26512984
http://dx.doi.org/10.1371/journal.pone.0141863
work_keys_str_mv AT chennanarendrasudeep localbutnotsystemicadministrationofuridinepreventsdevelopmentofantigeninducedarthritis
AT chalisejayaprakash localbutnotsystemicadministrationofuridinepreventsdevelopmentofantigeninducedarthritis
AT magnussonmattias localbutnotsystemicadministrationofuridinepreventsdevelopmentofantigeninducedarthritis
AT uppugundurisrinivas localbutnotsystemicadministrationofuridinepreventsdevelopmentofantigeninducedarthritis